TLPH (Talphera) Total Operating Expense: $14.52 Mil (TTM As of Mar. 2026)


TLPH Talphera Inc TLPH
34 GF Score
Price $1.05
! 3 Warning Signs
View Full Analysis

What is Talphera Total Operating Expense?

Talphera TLPH +2.44% 34 Total Operating Expense is $14.52 Mil as of Mar. 2026. GuruFocus rates TLPH with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Talphera's Total Operating Expense for the three months ended in Mar. 2026 was $3.95 Mil. Talphera's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $14.52 Mil.


Talphera Total Operating Expense Related Terms


Talphera Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Talphera's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Talphera Total Operating Expense Chart

Talphera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.03 19.53 17.54 15.25 13.51

Talphera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.94 3.69 3.42 3.45 3.95
TLPH
34GF Score
Talphera Inc TLPH
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Talphera Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $14.52 Mil mean?
Talphera (TLPH) has a Total Operating Expense of $14.52 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Talphera and its competitors.
Is Talphera's Total Operating Expense too high?
Talphera's current Total Operating Expense is $14.52 Mil. Overall, Talphera has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Talphera's Total Operating Expense compare to CTOR and ETST?
Talphera's Total Operating Expense of $14.52 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Talphera and its competitors. Talphera's current Total Operating Expense is $14.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talphera stock overvalued right now?
Talphera (TLPH) has a current Total Operating Expense of $14.52 Mil. The current Total Operating Expense is $14.52 Mil. Talphera's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Talphera (TLPH), the current Total Operating Expense is $14.52 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Talphera Business Description

Other Exchanges R5XA:Germany
Address 1850 Gateway Drive, Suite 175, San Mateo, CA, USA, 94404
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
34GF Score

Get the complete analysis for TLPH

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.05
Price